Skip to content
Certified ManufacturersFor manufacturers

STPCA DBA Sun Ten Laboratories

Irvine, CA, United States

Due-diligence report

Find an accredited testing lab and confirm its scope covers your product and methods.

STPCA DBA Sun Ten Laboratories is a dietary supplement manufacturer in Irvine, CA, United States, certified to NSF/ANSI 455-2 GMP, with 1 manufacturing facility on NSF’s public NSF/ANSI 455 listing as of November 19, 2026. Listed dosage forms: capsules, powders and tablets.

Website
sunten.com
Facilities listed
1
Last checked

Dosage forms

As listed in the product categories of this company’s NSF/ANSI 455-2 certified facilities.

Certified facilities

Manufacturing (1)

  • 9250 Jeronimo Road, Irvine, CA 92618, United States

    • Dry Formulation
    • Encapsulation
    • Mixing
    • Packaging/Labeling Operation
    • Packaging/Labeling Operation - Primary Packaging
    • Packaging/Labeling Operation - Secondary Packaging
    • Quality Unit Operations
    • Tablet Compression
    • Warehousing

How STPCA DBA Sun Ten Laboratories compares

Among the 769 manufacturers we list, as of our last check.

FDA recall records

No food or dietary supplement recall found under the name STPCA DBA Sun Ten Laboratories in FDA’s enforcement reports, as of .

We match FDA records by company name only. A recall listed under a different name won’t appear here, and a different company with the same name could. FDA’s food enforcement records start in June 2012. How we check

FDA inspections

FDA lists 8 food or dietary supplement inspections at facilities matching STPCA DBA Sun Ten Laboratories, from 2011 to 2025, as of . 1 found no objectionable conditions, 5 found conditions the firm was left to correct, and 2 led FDA to recommend official action.

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Irvine, California

    Listed by FDA as STPCA Inc.

    7 citations posted:

    • Specifications - components (21 CFR 111.70(b))
    • In-process specification (21 CFR 111.70(c)(1))
    • Specifications - finished dietary supplement (21 CFR 111.70(e))
    • Quality control - Laboratory control processes; production, process control (21 CFR 111.110)
    See all 7 citations
    • Specifications - components (21 CFR 111.70(b))

      For component(s) used in the manufacture of a dietary supplement, you did not establish identity specifications, necessary specifications to ensure the specifications for purity, strength, and composition of the dietary supplement are met and limits on contamination to ensure the quality of the dietary supplement.

    • In-process specification (21 CFR 111.70(c)(1))

      You did not establish in-process specifications for a point, step, or stage in the master manufacturing record where control is necessary to help ensure that specifications are met for strength and composition.

    • Specifications - finished dietary supplement (21 CFR 111.70(e))

      You did not establish product specifications for identity, strength and composition.

    • Quality control - Laboratory control processes; production, process control (21 CFR 111.110)

      Your quality control operations did not include ensuring that tests and examinations required for your laboratory operations were conducted and reviewing and approving the results of required tests and examinations.

    • Master manufacturing record - record requirements (21 CFR 111.210)

      Your master manufacturing record did not include all required information.

    • Batch record - required information (21 CFR 111.260)

      Your batch production record did not include all required information.

    • Standard reference materials; criteria for selecting (21 CFR 111.315(d))

      You did not establish laboratory control processes for use of criteria for selecting standard reference materials used in performing tests and examinations.

    FEI 3001687508

  • Official action indicated · Regulatory or administrative action recommended

    Inspected

    Irvine, California

    Listed by FDA as STPCA Inc.

    7 citations posted:

    • Specifications - component identity (21 CFR 111.70(b)(1))
    • Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))
    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))
    • Appropriate tests, examinations; certificate of analysis (21 CFR 111.75(a)(2))
    See all 7 citations
    • Specifications - component identity (21 CFR 111.70(b)(1))

      You did not establish an identity specification for each component.

    • Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))

      You did not establish component specifications for purity, strength and composition.

    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))

      You did not establish product specifications for the identity, purity, strength and composition of the finished dietary supplement.

    • Appropriate tests, examinations; certificate of analysis (21 CFR 111.75(a)(2))

      You did not conduct appropriate tests or examinations or rely on a certificate of analysis to determine whether components met established specifications.

    • Specifications met - verify; finished batch (21 CFR 111.75(c))

      You did not verify that your finished batch of dietary supplement meets product specifications for limits on contamination that may adulterate or that may lead to adulteration of the dietary supplement.

    • Quality control - production, process control (21 CFR 111.105(h))

      Your quality control personnel did not determine that specifications established for the production and process control system were met.

    • Master manufacturing record - controls, procedures (21 CFR 111.205(b)(2))

      Your master manufacturing record did not establish controls and procedures to ensure that each batch met specifications.

    FEI 3001687508

  • Official action indicated · Regulatory or administrative action recommended

    Inspected

    Irvine, California

    Listed by FDA as STPCA Inc.

    6 citations posted:

    • Specifications - component identity (21 CFR 111.70(b)(1))
    • Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))
    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))
    • Appropriate tests, examinations; certificate of analysis (21 CFR 111.75(a)(2))
    See all 6 citations
    • Specifications - component identity (21 CFR 111.70(b)(1))

      You did not establish an identity specification for each component.

    • Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))

      You did not establish component specifications for purity, strength and composition.

    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))

      You did not establish product specifications for the identity, purity, strength and composition of the finished dietary supplement.

    • Appropriate tests, examinations; certificate of analysis (21 CFR 111.75(a)(2))

      You did not conduct appropriate tests or examinations or rely on a certificate of analysis to determine whether components met established specifications.

    • Specifications met - verify; finished batch (21 CFR 111.75(c))

      You did not verify that your finished batch of dietary supplement meets product specifications for limits on contamination that may adulterate or that may lead to adulteration of the dietary supplement.

    • Quality control - production, process control (21 CFR 111.105(h))

      Your quality control personnel did not determine that specifications established for the production and process control system were met.

    FEI 3001687508

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Irvine, California

    Listed by FDA as STPCA Inc.

    5 citations posted:

    • Specifications - component identity (21 CFR 111.70(b)(1))
    • Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))
    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))
    • Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))
    See all 5 citations
    • Specifications - component identity (21 CFR 111.70(b)(1))

      You did not establish an identity specification for each component.

    • Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))

      You did not establish component specifications for purity, strength and composition.

    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))

      You did not establish product specifications for the identity, purity, strength and composition of the finished dietary supplement.

    • Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))

      You did not conduct at least one appropriate test or examination to verify the identity of a dietary ingredient, prior to its use.

    • Component - qualify supplier (21 CFR 111.75(a)(2)(ii)(A))

      You did not qualify a supplier of a component by establishing the reliability of the supplier's certificate of analysis through confirmation of the results of their tests or examinations.

    FEI 3001687508

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Irvine, California

    Listed by FDA as STPCA Inc.

    1 citation posted:

    • Component - qualify supplier (21 CFR 111.75(a)(2)(ii)(A))
    Full citation text
    • Component - qualify supplier (21 CFR 111.75(a)(2)(ii)(A))

      You did not qualify a supplier of a component by establishing the reliability of the supplier's certificate of analysis through confirmation of the results of their tests or examinations.

    FEI 3001687508

Show all 8 inspections
  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Irvine, California

    Listed by FDA as STPCA Inc.

    7 citations posted:

    • Specifications - components (21 CFR 111.70(b))
    • In-process specification (21 CFR 111.70(c)(1))
    • Specifications - finished dietary supplement (21 CFR 111.70(e))
    • Quality control - Laboratory control processes; production, process control (21 CFR 111.110)
    See all 7 citations
    • Specifications - components (21 CFR 111.70(b))

      For component(s) used in the manufacture of a dietary supplement, you did not establish identity specifications, necessary specifications to ensure the specifications for purity, strength, and composition of the dietary supplement are met and limits on contamination to ensure the quality of the dietary supplement.

    • In-process specification (21 CFR 111.70(c)(1))

      You did not establish in-process specifications for a point, step, or stage in the master manufacturing record where control is necessary to help ensure that specifications are met for strength and composition.

    • Specifications - finished dietary supplement (21 CFR 111.70(e))

      You did not establish product specifications for identity, strength and composition.

    • Quality control - Laboratory control processes; production, process control (21 CFR 111.110)

      Your quality control operations did not include ensuring that tests and examinations required for your laboratory operations were conducted and reviewing and approving the results of required tests and examinations.

    • Master manufacturing record - record requirements (21 CFR 111.210)

      Your master manufacturing record did not include all required information.

    • Batch record - required information (21 CFR 111.260)

      Your batch production record did not include all required information.

    • Standard reference materials; criteria for selecting (21 CFR 111.315(d))

      You did not establish laboratory control processes for use of criteria for selecting standard reference materials used in performing tests and examinations.

    FEI 3001687508

  • Official action indicated · Regulatory or administrative action recommended

    Inspected

    Irvine, California

    Listed by FDA as STPCA Inc.

    7 citations posted:

    • Specifications - component identity (21 CFR 111.70(b)(1))
    • Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))
    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))
    • Appropriate tests, examinations; certificate of analysis (21 CFR 111.75(a)(2))
    See all 7 citations
    • Specifications - component identity (21 CFR 111.70(b)(1))

      You did not establish an identity specification for each component.

    • Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))

      You did not establish component specifications for purity, strength and composition.

    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))

      You did not establish product specifications for the identity, purity, strength and composition of the finished dietary supplement.

    • Appropriate tests, examinations; certificate of analysis (21 CFR 111.75(a)(2))

      You did not conduct appropriate tests or examinations or rely on a certificate of analysis to determine whether components met established specifications.

    • Specifications met - verify; finished batch (21 CFR 111.75(c))

      You did not verify that your finished batch of dietary supplement meets product specifications for limits on contamination that may adulterate or that may lead to adulteration of the dietary supplement.

    • Quality control - production, process control (21 CFR 111.105(h))

      Your quality control personnel did not determine that specifications established for the production and process control system were met.

    • Master manufacturing record - controls, procedures (21 CFR 111.205(b)(2))

      Your master manufacturing record did not establish controls and procedures to ensure that each batch met specifications.

    FEI 3001687508

  • Official action indicated · Regulatory or administrative action recommended

    Inspected

    Irvine, California

    Listed by FDA as STPCA Inc.

    6 citations posted:

    • Specifications - component identity (21 CFR 111.70(b)(1))
    • Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))
    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))
    • Appropriate tests, examinations; certificate of analysis (21 CFR 111.75(a)(2))
    See all 6 citations
    • Specifications - component identity (21 CFR 111.70(b)(1))

      You did not establish an identity specification for each component.

    • Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))

      You did not establish component specifications for purity, strength and composition.

    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))

      You did not establish product specifications for the identity, purity, strength and composition of the finished dietary supplement.

    • Appropriate tests, examinations; certificate of analysis (21 CFR 111.75(a)(2))

      You did not conduct appropriate tests or examinations or rely on a certificate of analysis to determine whether components met established specifications.

    • Specifications met - verify; finished batch (21 CFR 111.75(c))

      You did not verify that your finished batch of dietary supplement meets product specifications for limits on contamination that may adulterate or that may lead to adulteration of the dietary supplement.

    • Quality control - production, process control (21 CFR 111.105(h))

      Your quality control personnel did not determine that specifications established for the production and process control system were met.

    FEI 3001687508

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Irvine, California

    Listed by FDA as STPCA Inc.

    5 citations posted:

    • Specifications - component identity (21 CFR 111.70(b)(1))
    • Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))
    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))
    • Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))
    See all 5 citations
    • Specifications - component identity (21 CFR 111.70(b)(1))

      You did not establish an identity specification for each component.

    • Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))

      You did not establish component specifications for purity, strength and composition.

    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))

      You did not establish product specifications for the identity, purity, strength and composition of the finished dietary supplement.

    • Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))

      You did not conduct at least one appropriate test or examination to verify the identity of a dietary ingredient, prior to its use.

    • Component - qualify supplier (21 CFR 111.75(a)(2)(ii)(A))

      You did not qualify a supplier of a component by establishing the reliability of the supplier's certificate of analysis through confirmation of the results of their tests or examinations.

    FEI 3001687508

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Irvine, California

    Listed by FDA as STPCA Inc.

    1 citation posted:

    • Component - qualify supplier (21 CFR 111.75(a)(2)(ii)(A))
    Full citation text
    • Component - qualify supplier (21 CFR 111.75(a)(2)(ii)(A))

      You did not qualify a supplier of a component by establishing the reliability of the supplier's certificate of analysis through confirmation of the results of their tests or examinations.

    FEI 3001687508

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Irvine, California

    Listed by FDA as STPCA Inc.

    4 citations posted:

    • Component - qualify supplier (21 CFR 111.75(a)(2)(ii)(A))
    • Components packaging, labels used (21 CFR 111.80(a))
    • Master manufacturing record - list components (21 CFR 111.210(b))
    • Master manufacturing record - sampling, tests, examinations (21 CFR 111.210(h)(2))
    Full citation text
    • Component - qualify supplier (21 CFR 111.75(a)(2)(ii)(A))

      You did not qualify a supplier of a component by establishing the reliability of the supplier's certificate of analysis through confirmation of the results of their tests or examinations.

    • Components packaging, labels used (21 CFR 111.80(a))

      You did not collect representative samples of each unique lot of packaging that you used to determine whether the packaging meet(s) established specifications.

    • Master manufacturing record - list components (21 CFR 111.210(b))

      Your master manufacturing record did not include a complete list of components to be used.

    • Master manufacturing record - sampling, tests, examinations (21 CFR 111.210(h)(2))

      The written instructions in your master manufacturing record did not include procedures for sampling and a cross-reference to procedures for tests or examinations.

    FEI 3001687508

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Irvine, California

    Listed by FDA as STPCA Inc.

    11 citations posted:

    • Equipment - automated - suitability (21 CFR 111.30(b))
    • Specifications - contamination limits (21 CFR 111.70(b)(3))
    • In-process identity, purity, strength, composition (21 CFR 111.70(c)(1))
    • Specifications - labels, packaging (21 CFR 111.70(d))
    See all 11 citations
    • Equipment - automated - suitability (21 CFR 111.30(b))

      You did not determine the suitability of the automated, mechanical, or electronic equipment by ensuring that the equipment is capable of operating satisfactorily within the operating limits required by the process.

    • Specifications - contamination limits (21 CFR 111.70(b)(3))

      You did not establish limits for contamination that may adulterate or may lead to adulteration of the finished dietary supplement.

    • In-process identity, purity, strength, composition (21 CFR 111.70(c)(1))

      You did not establish in-process specifications for a point, step, or stage in the master manufacturing record where control is necessary to help ensure that specifications are met for identity, purity, strength, and composition.

    • Specifications - labels, packaging (21 CFR 111.70(d))

      You did not establish packaging specifications.

    • Master manufacturing record - controls, procedures (21 CFR 111.205(b)(2))

      Your master manufacturing record did not establish controls and procedures to ensure that each batch met specifications.

    • Master manufacturing record theoretical and expected yield (21 CFR 111.210(f))

      Your master manufacturing record did not include a statement of the expected yield of the finished dietary supplement.

    • Packaging description, representative label (21 CFR 111.210(g))

      Your master manufacturing record did not include a a representative label, or a cross-reference to the physical location of the actual or representative label.

    • Corrective action plans (21 CFR 111.210(h)(5))

      The written instructions in your master manufacturing did not include instructions for corrective action plans to use when specifications are not met.

    • Batch record - follow master (21 CFR 111.255(c))

      Your batch production record did not accurately follow the appropriate master manufacturing record.

    • Batch record - initials; component (21 CFR 111.260(j)(2)(iii))

      Your batch production records did not include the initials of the person responsible for adding a component to the batch.

    • Batch record - initials; verifying component (21 CFR 111.260(j)(2)(iv))

      Your batch production records did not include initials of the person responsible for verifying the addition of components to the batch.

    FEI 3001687508

  • No action indicated · No objectionable conditions found

    Inspected

    Irvine, California

    Listed by FDA as STPCA Inc.

    FEI 3001687508

We match FDA inspections to companies by facility ZIP code (or city outside the US) and company name, so an inspection filed under a different name won’t appear here. FDA publishes final classifications only, and holds some back while enforcement is pending. Posted citations may differ from FDA’s final findings. FDA Data Dashboard · How we check

What we checked, and what we didn’t

Confirmed from NSF’s public listing

Last checked

  • NSF/ANSI 455-2 GMP certification
  • 1 facility address
  • Dosage forms in the certified scope
  • Operations listed for each facility

Not verified by us

  • Minimum order quantity (MOQ): the smallest order they accept
  • Lead times and current capacity
  • Prices
  • Other certifications, like organic, kosher, halal or NSF Certified for Sport
  • Whether they’re taking new clients
  • Conditions inside the facility. We don’t visit or audit facilities.

Ask about these in your quote request. How we verify

Other capsule manufacturers in the United States

  1. NSF lists 5 capsule facilities, including one in Tempe, AZ

    Tempe, AZ, United States21stcenturyvitamins.com

    • Capsules
    • Gummies
    • Softgels
    • Tablets
    Operations:
    • Kitting
    • Coating
    • Tablet compression
    • Encapsulation
    NSF/ANSI 455-2checked Nov 19, 2026
  2. NSF lists a capsule facility in Centennial, CO

    Centennial, CO, United States5280smc.com

    • Capsules
    Operations:
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026
  3. NSF lists a capsule facility in Garden Grove, CA

    Garden Grove, CA, United Statespackaging.com

    • Capsules
    • Gummies
    • Powders
    • Softgels
    • Tablets
    NSF/ANSI 455-2checked Nov 19, 2026
  4. NSF lists a capsule facility in Ada, MI

    Ada, MI, United Statesamway.com

    • Capsules
    • Powders
    • Softgels
    • Tablets
    Operations:
    • Kitting
    • Coating
    • Tablet compression
    • Encapsulation
    • +1 more
    NSF/ANSI 455-2checked Nov 19, 2026
  5. NSF lists 2 capsule facilities, including one in Chandler, AZ

    Gilbert, AZ, United Statesadeptlifesciences.com

    • Capsules
    • Liquids
    • Powders
    • Tablets
    Operations:
    • Liquid formulation
    • Tablet compression
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026
  6. NSF lists a capsule facility in Congers, NY

    Congers, NY, United Statesadhhealth.com

    • Capsules
    • Oils
    • Powders
    • Tablets
    Operations:
    • Coating
    • Tablet compression
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026